Philip Morris International Inc. logo

Philip Morris International Inc. (PM)

Market Closed
9 Jul, 20:00
NYSE NYSE
$
177. 98
+0.26
+0.15%
$
278.43B Market Cap
18.34 P/E Ratio
0% Div Yield
3,820,800 Volume
6.08 Eps
$ 177.72
Previous Close
Day Range
176.3 179.6
Year Range
101.62 186.69
Want to track PM and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Earnings results expected in 11 days
Bull of the Day: Philip Morris Intl (PM)

Bull of the Day: Philip Morris Intl (PM)

Philip Moriss is strategically evolving beyond its traditional cigarette business, exemplified by the remarkable success of its "Zyn" oral nicotine patch.

Zacks | 3 weeks ago
ZYN and IQOS Scale Up: Is Philip Morris Leading the Industry Reset?

ZYN and IQOS Scale Up: Is Philip Morris Leading the Industry Reset?

PM sees smoke-free products drive 44% of Q1 profit as ZYN and IQOS momentum redefines its future beyond tobacco.

Zacks | 3 weeks ago
Philip Morris Stock Records 50% YTD Surge: Is it Too Late to Buy?

Philip Morris Stock Records 50% YTD Surge: Is it Too Late to Buy?

PM stock soars 50.1% year to date, fueled by smoke-free growth, premium pricing and bullish earnings momentum.

Zacks | 1 month ago
Philip Morris International, Inc. (PM) dbAccess Global Consumer Conference Call Transcript

Philip Morris International, Inc. (PM) dbAccess Global Consumer Conference Call Transcript

Philip Morris International, Inc. (NYSE:PM ) dbAccess Global Consumer Conference Call June 3, 2025 5:15 AM ET Company Participants Emmanuel Babeau - CFO Conference Call Participants Damian McNeela - Deutsche Bank Damian McNeela Good morning, everybody. I think we will make a start.

Seekingalpha | 1 month ago
This Isn't The Philip Morris You Think It Is

This Isn't The Philip Morris You Think It Is

Philip Morris is leading the industry transition to smoke-free products, with 42% of revenue now from alternatives like IQOS and Zyn. Strong Q1 2025 results—10.2% organic revenue growth, rising margins, and raised earnings guidance—demonstrate robust financial health and execution. Despite a premium valuation and some regulatory and competitive risks, PM's stable cash flow and dividend growth justify a strong buy rating.

Seekingalpha | 1 month ago
Phillip Morris's Undeniable Market Leadership Comes At Too Great A Cost

Phillip Morris's Undeniable Market Leadership Comes At Too Great A Cost

PM's market leadership in the tobacco market across combustible and smoke-free approaches has been well rewarded indeed, as observed in the premium valuations and inflated stock prices. These have been well supported by the growing net revenues, the expanding shipment volumes, and the richer adj operating margins, significantly aided by the US FDA approval for ZYN. This is on top of the rich cash flow story, with PM's dividend remaining safe despite the management's intensified US-based capex thus far.

Seekingalpha | 1 month ago
Philip Morris (PM) Up 3% Since Last Earnings Report: Can It Continue?

Philip Morris (PM) Up 3% Since Last Earnings Report: Can It Continue?

Philip Morris (PM) reported earnings 30 days ago. What's next for the stock?

Zacks | 1 month ago
PM Stock Up 6.9% Post Q1 Earnings: A Green Light for Investors?

PM Stock Up 6.9% Post Q1 Earnings: A Green Light for Investors?

PM shows strong growth prospects, driven by its successful shift to smoke-free products, solid first-quarter results and optimistic guidance.

Zacks | 2 months ago
Philip Morris: A Bold Pivot That Worked

Philip Morris: A Bold Pivot That Worked

Philip Morris has successfully pivoted from cigarettes to non-combustible products, with IQOS leading the charge, achieving significant market share and revenue milestones. IQOS, PM's heat-not-burn brand, has outpaced traditional cigarette sales, particularly in Japan, and contributed $11B to PM's $15B smoke-free revenues in 2024. PM's acquisition of Swedish Match and its Zyn brand has bolstered its position in the oral nicotine market, adding $2B in sales and high margins in the critical US market.

Seekingalpha | 2 months ago
Top Wall Street analysts are bullish on these 3 dividend stocks for stable returns

Top Wall Street analysts are bullish on these 3 dividend stocks for stable returns

TipRanks' analyst ranking service spotlights three dividend-paying stocks, including AT&T and Texas Instruments.

Cnbc | 2 months ago
3 Dividend Kings Outshining the Market in 2025

3 Dividend Kings Outshining the Market in 2025

So far, 2025 hasn't exactly been kind to investors. The S&P 500 is down 5.5% year-to-date, weighed down by mounting uncertainty, tariffs, fears of an economic slowdown, and concerns over stretched valuations, particularly in growth-oriented technology stocks.

Marketbeat | 2 months ago
Philip Morris Torches Analyst Estimates, Attractive Long-Term Upside Ahead

Philip Morris Torches Analyst Estimates, Attractive Long-Term Upside Ahead

Philip Morris's Zyn is experiencing explosive growth, with US shipments up 53% and international volumes up 182% year-over-year. PM beat earnings estimates last week and raised guidance after crushing analyst forecasts. The company is in the process of building a massive Zyn factory in Colorado to meet soaring demand, positioning itself for significant future earnings growth.

Seekingalpha | 2 months ago
Loading...
Load More